MannKind MNKD (NASDAQ:MNKD) Stock Trading Idea: 41.5% Return in 1 Month
SmarTrend alerted Subscribers to an uptrend on MannKind (NASDAQ:MNKD) on November 17, 2009 at $6.77. In severely 1 month, MannKind has returned 41 ...
News Update: MannKind Sinks After FDA Withheld Approval, Requested Updated Safety Info
Shares of MannKind (NASDAQ:MNKD) are trading 8.8% lessen to $9.56 Monday after the company failed to win approval from US regulators to market its ...
Top Biotech. Stocks Trading Higher (CTIC, AEN, GILD, MNKD) | MBPE ...
Cubicle Therapeutics, Inc. (NASDAQ:CTIC) added 3.15% to $0.449. The hoard has a 52-week across of $0.12-$0.80.
The funds has for the most part always amount of 4.86 million...
MannKind Corporation (NASDAQ: MNKD) 3 Months Price Target Q1 2011
Is a biopharmaceutical ensemble that focuses on the development, advance and commercialization of salutary products for diseases such as diabetes and cancer. Their diva investigational...
MannKind (NASDAQ:MNKD) Conference Call Paints a Challenging Future ...
The Pty is focusing the magnitude of their resources on getting Afrezza to merchandise. As such, 179 people were let go from MannKind yesterday, representing a 41% reduction in payroll. And although MannKind didn’t explicitly pomp that the oncology program was cut, they did note that only ‘important personnel’ would be retained. Additionally, the crowd will be conducting an internal audit of inquiry programs in the near time to come and adjudicate which programs will be entranced foremost, and which will be halted or sold.
...| Volume Gainers at NASDAQ – AMAT, MNKD, STX, FLEX, WIN | TechWeek
AMAT sum total for the last trading meeting was 12.78 million shares and fresh expense haughtiness from SMA50 remained 11.71%. Applied Materials, Inc. provides nanomanufacturing technology solutions for the semiconductor, outspread panel demonstrate, solar, and cognate industries worldwide. Its Silicon fragment provides a choice of manufacturing paraphernalia tempered to to fake semiconductor chips or integrated circuits.
...NASDAQ Volume Active Stocks are – RPRX, SNDK, MNKD, AMGN, ATML ...
Repros Therapeutics Inc. (Custom, NASDAQ:RPRX) decreased -4.42%, currently trading at $3.24 and its blanket traded loudness was 1.94M shares while reporting, against its regular book of 1.41M. RPRX opened the day at $3.48, it made an intraday low of $3.18 and an intraday considerable of $3.74. The ancestor has a 52 week low of $1.11 and 52 week intoxicated of $4.88. RPRX’s Stock Exchange capitalization is 28.93M and it has 8.93M owed shares.
...Nasdaq Mnkd - News
|
MannKind Corporation to Hold 2011 Fourth Quarter and Full Year Financial ... MannKind Corporation (Nasdaq: MNKD) will release its 2011 fourth phase of the moon and full year financial results on Wednesday, February 22, 2012 and its management will host a conference call to discuss the fourth chambers and full year financial results and |
|
MannKind to Present at Upcoming Conferences MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will for the time being at upcoming conferences. Interested parties can access a link to the live webcast of |
|
MannKind Announces Pricing Of Public Offering Of Units Consisting Of Common ... By Obligation Wire 02/02/12 - 09:38 PM EST MannKind Corporation (Nasdaq: MNKD) today announced the pricing of an underwritten public offering of 31250000 units, with each portion consisting of one share of its common stock and a warrant to purchase 0.6 of a |
